Council

Professor John Hay AC

BA (Hons) (Western Australia and Cambridge) MA (Cambridge) PhD (Western Australia) Hon LittD (Deakin) Hon DLitt. (UWA) Hon DU (QUT) Hon LLD (Queensland) FAHA FACE FAIM FQA

Professor Hay is Chair of QIMR Council.

Professor Hay was Vice-Chancellor of The University of Queensland from 1996–2007. In that time, he led the development of many major new research institutes including

the Institute for Molecular Bioscience and the Queensland Brain Institute. He was also instrumental in securing funding for the Translational Research Institute to be built at the Princess Alexandra Hospital.

Under his leadership, both Deakin University and The University of Queensland were named Australian Universities of the Year by the Good Universities Guide.

Professor Hay was appointed as Chair of QIMR by the Queensland Government in September 2009.

Mr Christopher Coyne

Christopher Coyne is the Deputy Chair of QIMR Council.

Mr Coyne is a solicitor of the Supreme Court of Queensland, an accredited specialist in the field of Commercial Litigation, specialising in insurance law, health law, corporate governance and risk management. Following his admission as a solicitor in 1979 he practised law in Brisbane and was a partner in the national law firm Clayton Utz from 1984 to 2004.

Mr Coyne now practices on his own account. He was appointed an Adjunct Professor of The University of Queensland School of Law in 2002. Chris is Board Chairman of Lexon Insurance Pte Ltd (Queensland Law Society, Singapore Captive Insurer), a Director of the Incorporated Council of Law Reporting for the State of Queensland,

past president Medico-Legal Society of Queensland and Australian Insurance Law Association and former legal member Australian Health Ethics Committee. Christopher is a

sessional member of the Queensland Civil and Administrative Tribunal and also a member of the QIMR Personnel Administration Committee.

Professor Bryan Campbell AM

MD BS FRACP FRACMA

Professor Campbell was formerly Chief Health Officer of Queensland and Head of The University of Queensland Medical School.

He has been a Councillor of the Royal Australasian College of Physicians, the Royal Australian College of Medical Administrators and a member of the National Health and Medical Research Council (NHMRC). He was Deputy Chair of the Australian Health Ethics Committee and a member of the NHMRC Embryo Research Licensing Committee until June 2006.

Professor Campbell is the Chair of the QIMR Finance and Audit Committee.

Professor Judith Clements

BAppSc MAppSc PhD

Professor Clements has over 20 years’ experience as a basic researcher in biomedical research, primarily in the general field of molecular endocrinology.Her current research seeks understanding of the molecular basis of hormone dependent cancers such as prostate and ovarian cancer.

She is currently Scientific Director of the Australian Prostate Cancer Research Centre-Queensland and Program Leader of the Cancer Program within the Institute of Health and Biomedical Innovation at the Queensland University of Technology. She coordinates the Australian Prostate Cancer BioResource, a national tissue bank for prostate cancer research. She is also an NHMRC Principal Research Fellow and an NHMRC Academy member since 2009. In 2007 Professor Clements was awarded the prestigious international Frey-Werle Foundation Gold Medal for her significant contributions to the kallikrein protease field.

Professor Clements is Chair of the QIMR Appointment and Promotions Committee.

Associate Professor Paula Marlton

MB BS (Hons I) FRACP FRCPA

Paula Marlton is the Head of Leukaemia and Lymphoma Services at the Princess Alexandra Hospital where she is also Deputy Director of Haematology. Her previous appointments include three years at the MD Anderson Cancer Centre in Houston, Texas. She has extensive experience in clinical research including the role of principal investigator for national multi-centre trials and supervisor of molecular translational research associated with trials. She was the founding Chair of the Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Committee and has established and continues to direct the ALLG Tissue Bank. Her other professional roles include Medical Advisor and Board member of the Leukaemia Foundation, member of several Drug Advisory Boards and Government and College Advisory Committees as well as a wide range of academic and clinical service roles.

Dr Jeannette Young

MB BS FRACMA AFACHSE

Dr Jeannette Young is the Chief Health Officer for Queensland, a role she has filled since August 2005. Prior to this, she held the position of Executive Director of Medical Services at the Princess Alexandra Hospital in Brisbane and has previously worked in a range of positions in Queensland and Sydney. She has specialist qualifications as a Fellow of the Royal Australasian College of Medical Administrators and as a Fellow by Distinction of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom. She is an Adjunct Professor at Queensland University of Technology and at Griffith University.

Today she is responsible for such matters as health disaster planning and response, aero-medical retrieval services, licensing of private pospitals, organ and tissue donation services, provision of health services to prisoners, cancer screening services, communicable diseases, environmental health and other population health services and mental health, alcohol and other drugs policy and legislation.

Along with sitting on the QIMR Council, Dr Young is a member of numerous State and National committees and Boards, some of which include the Queensland Board of the Medical Board of Australia, NHMRC, the Australian Health Protection Committee, the Clinical Technical Ethical Principal Committee of Australian Health Ministers’ Advisory Council, the Australian Population Health Development Principal Committee and the newly created Australian National Preventive Health Agency Advisory Council.

Professor Alan Pettigrew

BSc (Hons) PhD FAICD

Professor Pettigrew holds the degrees of Bachelor of Science and Doctor of Philosophy from the University of Sydney and is a Fellow of the Australian Institute of Company Directors. He has held a range of academic and senior executive appointments at a number of Australian Universities, having served as Deputy Chair of the Academic Board at the University of Sydney, Pro Vice-Chancellor (Biological Sciences) at The University of Queensland, and Deputy Vice-Chancellor (Academic) at the University of NSW.

In January 2001, Professor Pettigrew was appointed by the Commonwealth Minister for Health and Aging as the inaugural Chief Executive Officer of the National Health and Medical Research Council. He served in that role until the end of 2005 when he was appointed as the Vice-Chancellor and Chief Executive Officer of the University of New England. Professor Pettigrew retired from the University in 2009. He also served as a member of the Board of the Australian Universities Quality Agency until 2010.

Professor Pettigrew is currently an Adjunct Professor in the College of Medicine, Biology and Environment at the Australian National University and an Honorary Professorial Fellow at the University of Melbourne. He is a member of the Advisory Board of the L.H. Martin Institute for Higher Education Leadership and Management, and the Advisory Council of Research Australia Philanthropy. Professor Pettigrew is a member of the Cooperative Research Centres Committee of the Australian Government and has been appointed as an adviser to the Chief Scientist of Australia. He is also a consultant to universities on higher education leadership, management and research.

 

Mr Rodney Wylie OBE

BComm BA FCA FAICD

Rod Wylie is a Brisbane-based chartered accountant with substantial experience in investment, company management and corporate governance issues across a wide range of organisations, in many cases with nationwide and international activities.

He has been involved through Board or Council membership in the administration of a number of professional and community not-for-profit groups.

Mr Wylie chairs the QIMR Investment Committee and is a member of the QIMR Finance and Audit Committee and QIMR Personnel Administration Committee.

Mr Greg Baynton B Bus M Econ St MBA FFINSA

Greg Baynton is the founder and Managing Director of Orbit Capital, a boutique investment and advisory company. He comes from a background in merchant banking and Queensland Treasury, and has experience in infrastructure investment, capital raisings, IPOs, pre-IPO funding, corporate structuring and corporate governance.

Mr Baynton is currently Director of Lodestone Energy Limited (formerly Lodestone Exploration Limited), and Tissue Therapies Limited. Previously Mr Baynton was a Director of PIPE Networks Limited.

Mr Baynton holds a Bachelor of Business (Accountancy), a Master of Economic Studies (UQ), a Post-graduate Diploma in Applied Finance & Investment (SIA), and a Master of Business Administration (QUT).

Mr Baynton is a Fellow of the Financial Services Institute of Australasia.

Professor Nick Fisk

MBBS PhD MBA FRANZCOG FRCOG DDU CMFM

Professor Fisk was appointed Executive Dean of Health Sciences at The University of Queensland in 2010. He practices as a maternal-fetal medicine specialist and high risk obstetrician at the Royal Brisbane and Women's Hospital, and maintains a research group in The University of Queensland Centre for Clinical Research (UQCCR).

Between 1992-2007 he was Professor of Obstetrics and Fetal Medicine at Imperial College and Queen Charlotte's Hospital, London, where his laboratory and clinical research program achieved an international reputation in fetal diagnosis and treatment. His main research interests have been in human fetal mesenchymal stem cell biology and monochorionic multiple pregnancy, but also spanned non-invasive prenatal diagnosis, fetal nociception, caesarean section, preterm labour, obstetric ultrasound and drug development in obstetrics. A fetal-medicine subspecialist with an MBA and a PhD in fetal physiology, he has authored nearly 400 publications, and is a past President of the International Fetal Medicine and Surgery Society. He reviews for numerous international grant bodies, and is a member of several editorial boards including PLoS Medicine.

He is passionate about driving clinical research in a bench to bedside environment, to link wet and dry laboratories with patients, and to foster the training of tomorrow's translational researchers.